Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Adaptogens in Patients with Long COVID-19: A Randomized, Quadruple-Blind, Placebo-Controlled Trial
Authors
Keywords
-
Journal
Pharmaceuticals
Volume 15, Issue 3, Pages 345
Publisher
MDPI AG
Online
2022-03-14
DOI
10.3390/ph15030345
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
- (2022) Francisco Mera-Cordero et al. Trials
- Effects of Chinese Medicine on Symptoms, Syndrome Evolution, and Lung Inflammation Absorption in COVID-19 Convalescent Patients during 84-Day Follow-up after Hospital Discharge: A Prospective Cohort and Nested Case-Control Study
- (2021) Li Li et al. Chinese Journal of Integrative Medicine
- Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital
- (2021) Nan-Hui Zhang et al. BMC INFECTIOUS DISEASES
- Role of interleukin 6 as a predictive factor for a severe course of Covid-19: retrospective data analysis of patients from a long-term care facility during Covid-19 outbreak
- (2021) P. Sabaka et al. BMC INFECTIOUS DISEASES
- Neuron-specific enolase serum levels in COVID-19 are related to the severity of lung injury
- (2021) Erika Cione et al. PLoS One
- Acute Kidney Injury in COVID-19
- (2021) Marta Głowacka et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Kidney Outcomes in Long COVID
- (2021) Benjamin Bowe et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Long COVID and kidney disease
- (2021) Sachin Yende et al. Nature Reviews Nephrology
- Levocetirizine and montelukast in the COVID-19 treatment paradigm
- (2021) Bruce Chandler May et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
- (2020) Mark W. Tenforde et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Evolution of the adaptogenic concept from traditional use to medical systems: Pharmacology of stress‐ and aging‐related diseases
- (2020) Alexander G. Panossian et al. MEDICINAL RESEARCH REVIEWS
- How and Why Patients Made Long Covid
- (2020) Felicity Callard et al. SOCIAL SCIENCE & MEDICINE
- The Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections
- (2020) Alexander Panossian et al. Pharmaceuticals
- Defining IL‐6 levels in healthy individuals: A meta‐analysis
- (2020) Elias A. Said et al. JOURNAL OF MEDICAL VIROLOGY
- Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions
- (2010) G. Aslanyan et al. PHYTOMEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More